Loading clinical trials...
Loading clinical trials...
The New Enrollment Post-Approval Study is designed to evaluate the safety and efficacy of the Esteem Totally Implantable Hearing System in subjects suffering from moderate to severe hearing loss.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Envoy Medical Corporation
NCT05572073 · Sensorineural Hearing Loss, Bilateral
NCT07356128 · Bilateral Sensorineural Hearing Loss, Cochlear Implant, and more
NCT06936449 · Sensorineural Hearing Loss, Bilateral Hearing Loss
NCT04591093 · Sensorineural Hearing Loss, Bilateral
NCT06229717 · Children, Only, Vestibular Disorder, and more
North Alabama ENT Associates
Madison, Alabama
Pacific Hearing Service
Los Altos, California
Ear, Nose, & Throat Associates of South Florida
Jupiter, Florida
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions